| | MI |
|---|
| Variable: N (%) or mean (SD)* | Type 1 | Type 2 | P value |
|---|
| N | 293 | 303 | |
| Age | 51 (9) | 49 (11) | 0.02 |
| Female (%) | 49 (17) | 82 (27) | 0.002 |
| Ethnicity | | | < 0.001 |
| White | 149 (51) | 73 (24) | |
| Black | 115 (39) | 205 (68) | |
| Hispanic | 20 (7) | 18 (6) | |
| Other/missing | 9 (3) | 7 (2) | |
| Log10(HIV viral load (VL) + 1) | 2.4 (1.4) | 3.1 (1.6) | < 0.001 |
| Log10(max VL + 1) | 4.8 (1.1) | 4.9 (1.1) | 0.3 |
| CD4 | 436 (304) | 333 (292) | < 0.001 |
| Nadir CD4 | 174 (174) | 168 (201) | 0.7 |
| BMI** | | | < 0.001 |
| < 18.5 | 13 (4) | 31 (10) | |
| 18.5 to < 25 | 111 (38) | 138 (46) | |
| 25 to < 30 | 100 (34) | 64 (21) | |
| ≥ 30 | 60 (20) | 45 (15) | |
| Missing BMI | 9 (3) | 25 (8) | |
| Diabetes | 74 (25) | 69 (23) | 0.5 |
| eGFR < 30 mL/min/1.73m2 | 33 (11) | 51 (17) | 0.05 |
| Statin use | 84 (29) | 41 (14) | < 0.001 |
| Treated hypertension | 98 (33) | 93 (31) | 0.5 |
| Smoker | 134 (46) | 130 (43) | 0.5 |
- *Demographic and clinical characteristics are derived from the most recent visit prior to MI
- **9 people with type 1 MI were missing BMI measurements (7 of whom died during follow-up) and 25 people with type 2 MI were missing BMI measurements (19 of whom died during follow-up)
